Abstract
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia
Highlights
Based on high-quality evidence, the document outlines current should be treated with antihypertensive therapy with the target to global standards for the risk stratification, monitoring, and manageachieve systolic blood pressure and diastolic blood pressure equal to or ment of pre-eclampsia in the second and third trimester of pregnancy
32 Women were eligible for enrolment when they presented ease preterm. We suggest their use alongside clinical assessment to with either elevated blood pressure or proteinuria and/or symphelp rule out pre-eclampsia in women suspected of developing the toms such as headache, visual symptoms, right upper quadrant
We suggest expectant management be considered for women with pre-eclampsia at
Summary
The authors acknowledge the important contributions provided by the international expert members of FIGO’s Pregnancy and Non-Communicable Diseases. Committee during the creation of the document. For FIGO guidance and coordination, go to President Carlos Fuchtner, President-Elect Jeanne. Special thanks to Rachel Gooden, FIGO Project Manager
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology & Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
